BSX
Boston Scientific Corporation
Boston Scientific is a large-cap medical device maker whose political relevance centers on FDA regulation, Medicare/Medicaid reimbursement, and medical-device tax policy.
Next filing → your inbox
Govt Dependence
55/100
Regulatory Density
72/100
Lobbying Intensity
45/100
Political Signal
MEDIUM
BusinessWhat BSX does
Boston Scientific develops and manufactures medical devices across cardiovascular, rhythm management, endoscopy, urology, and neuromodulation segments. Primary revenue comes from device sales to hospitals and physicians, with reimbursement heavily influenced by CMS coverage and rates.
12 months past · 3 months futureBSX activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
246 trading days ·
30 congressional trades shown
·
0 insider buys
·
12 13F filings
·
0 past bill actions
·
9 upcoming markups
Executive Branch ConflictsBSX held by Trump-administration officials
2 cabinet/senior officials reported BSX positions in OGE Form 278 disclosures across 42 filings.
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP COM
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP COM
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Donald J. Trump
President · White House
BOSTON SCIENTIFIC CORP
Lifetime Government AwardsBSX federal contracts by year
$38M
total awarded · 2007–2013
1000
contracts on file
2012
peak year ($25M)
Top contracts by award amount
$2.8M
Department of Veterans Affairs
2007-05-01
STENT CONSIGNMENT
$910K
Department of Veterans Affairs
2007-09-01
CONSIGNMENT AGREEMENT
$409K
Department of Veterans Affairs
2012-10-10
EXPRESS REPORT-PROSTHETICS
$399K
Department of Veterans Affairs
2011-12-12
CRT PRODUCTS
$338K
Department of Veterans Affairs
2012-10-01
EXPRESS REPORTS - TO CAPTURE ALL PROSTHETICS PURCHASE ORDERS FROM OCTO
7 years · 1000 contracts
Smart Money · 13F HoldingsHedge funds holding BSX
$796.37B
Total BSX held by tracked 13F funds
7
Funds with BSX positions
Two Sigma Investments
$590.55B
+281%
7 overlap
2026-03-31
Renaissance Technologies
$197.79B
+32%
7 overlap
2026-03-31
Lone Pine Capital
$6.57B
-48%
7 overlap
2026-03-31
D.E. Shaw & Co.
$856M
+19%
20 overlap
2025-12-31
Citadel Advisors
$353M
-48%
20 overlap
2025-12-31
Viking Global Investors
$239M
holds
20 overlap
2025-12-31
Bridgewater Associates
$9M
-41%
20 overlap
2025-12-31
Politicians Trading BSXMembers of Congress with recent BSX positions
10 politicians traded BSX across 71 disclosed transactions totaling $740K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just BSX). 0-30 LOW · 30-60 MID · 60+ HIGH.
Gilbert Ray Cisneros
9 buys
16 sells
$200K
2026-08-18
HIGH · 61
Ro Khanna
10 buys
8 sells
$193K
2026-08-10
LOW · 0
Lisa C. McClain
4 buys
6 sells
$80K
2025-10-31
LOW · 0
Jefferson Shreve
2 sells
$65K
2025-05-12
LOW · 0
Kevin Hern
2 sells
$65K
2025-10-28
LOW · 1
Markwayne Mullin
1 buy
$33K
2025-12-29
LOW · 29
Bruce Westerman
2 buys
2 sells
$32K
2025-04-21
LOW · 0
Val T. Hoyle
2 buys
2 sells
$32K
2025-09-23
LOW · 0
John Boozman
2 buys
2 sells
$32K
2026-06-04
MID · 47
Michael T. McCaul
1 buy
$8K
2026-03-27
LOW · 0
Congressional TradesWho in Congress is trading BSX
2026-08-18
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-08-10
Ro Khanna
Purchase
$1,001 - $15,000
2026-07-07
Ro Khanna
Sale
$1,001 - $15,000
2026-06-04
John Boozman
Sale
$1,001 - $15,000
2026-06-02
Ro Khanna
Purchase
$1,001 - $15,000
2026-06-05
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-05-29
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-05-19
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-05-11
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-03-27
Michael T. McCaul
Purchase
$1,001 - $15,000
2026-03-30
Ro Khanna
Purchase
$15,001 - $50,000
2026-02-10
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-09-11
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting BSXLive legislation impacting this stock
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HR.1784 · 119th
Medicare Fraud Detection and Deterrence Act of 2025
HR.1776 · 119th
New Health Options Act of 2025
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.786 · 119th
Public Health Funding Restoration Act
S.763 · 119th
Telehealth Expansion Act of 2025
HR.920 · 119th
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
SRES.90 · 118th
A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "En
S.606 · 118th
Protecting Americans from Dangerous Opioids Act
Political ProfileWhere BSX sits in Washington
bipartisan
BSX shares can move on CMS reimbursement decisions, FDA approvals/recalls, and device-tax policy, but broad legislative news rarely drives large single-day moves.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA 510(k)/PMA regulatory tightening
- CMS reimbursement rate cuts
- medical device tax reinstatement
- product liability litigation
Regulatory opportunities
- expanded Medicare device coverage
- FDA approval pathway modernization
- new-technology add-on payments
LobbyingWho's hired to advocate for BSX
AdvaMedMedical Device Manufacturers Association
Member intelligence layer
Live signals + predictions for BSX — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades BSX
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout BSX & political exposure
Does Boston Scientific Corporation (BSX) hold federal contracts?
Yes. Boston Scientific Corporation has 9585 federal contract awards totaling $412,442,159, primarily from agencies including Department of Defense, Department of Health and Human Services, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own BSX stock?
2 Trump cabinet members or senior White House staff have disclosed holdings in BSX on their OGE 278 financial disclosures, including Donald J. Trump, Lori Chavez-DeRemer. See the Cabinet Conflicts panel for details.
Has Congress traded BSX stock?
345 congressional trades by 22 unique members of Congress, most recently on 2026-08-18. See the Congressional Trading panel for politician-by-politician breakdown.
What is BSX political risk profile?
Government dependence: 55/100. Lobbying intensity: 45/100. Political signal: medium. Donor party split: bipartisan.
How does GovGreed track BSX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. BSX data is updated daily from these official federal sources.